Bacteroides fragilis
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2023 (NCT06026397)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Bacteroides fragilisSupplementation
Bacteroides fragilis supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07309315 | N/A | Dec 15, 2025 | Southern Medical University |
| NCT06026397 | Phase 1 | Aug 1, 2023 | Guangzhou Zhiyi Biotechnology |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Guangzhou Zhiyi Biotechnology | For profit | 1 | 1 | 1 | 2023 |
| Southern Medical University | Academic/Hospital | 1 | 1 | 1 | 2025 |
2 organizations
Page 1 / 1